NovaBay Pharmaceuticals, Inc. Non-current Liabilities (Other)

Non-current Liabilities (Other) of NBY for past 10 years: annual, quarterly and twelve month trailing (TTM) including Non-current Liabilities (Other) growth rates and interactive chart.


Highlights and Quick Summary

  • Non-current Liabilities (Other) for the quarter ending June 30, 2022 was $342 Thousand (a 0.0% decrease compared to previous quarter)
  • Year-over-year quarterly Non-current Liabilities (Other) increased by Infinity%
  • Annual Non-current Liabilities (Other) for 2021 was $10.1 Million (a Infinity% increase from previous year)
  • Annual Non-current Liabilities (Other) for 2020 was $0 (a -100.0% decrease from previous year)
  • Annual Non-current Liabilities (Other) for 2019 was $4.06 Million (a 978.46% increase from previous year)
Visit stockrow.com/NBY for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Non-current Liabilities (Other) of NovaBay Pharmaceuticals, Inc.

Most recent Non-current Liabilities (Other)of NBY including historical data for past 10 years.

Interactive Chart of Non-current Liabilities (Other) of NovaBay Pharmaceuticals, Inc.

NovaBay Pharmaceuticals, Inc. Non-current Liabilities (Other) for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 $0.34 $0.34
2021 $10.12 $0.0 $10.12
2020 $0.0 $7.69 $3.94 $0.0
2019 $4.06 $4.22 $1.2 $0.81 $4.06
2018 $0.38 $0.72 $0.98 $1.47 $0.38
2017 $1.69 $2.11 $1.83 $1.9 $1.69
2016 $1.64 $2.53 $2.26 $1.84 $1.64
2015 $1.45 $0.14 $0.14 $1.45
2014 $0.17 $0.62 $0.52 $1.32 $0.17
2013 $1.84 $2.56 $1.7 $1.8 $1.84
2012 $1.28 $1.92 $2.13 $2.76 $1.28
2011 $2.72 $2.72

Business Profile of NovaBay Pharmaceuticals, Inc.

Sector: Healthcare
Industry: Biotechnology